Harmony Biosciences: Funding, Investors & Team (Sep 2026)
Harmony Biosciences, located in Plymouth Meeting, PA, is a pharmaceutical company that was founded in October 2017. Their goal is to create and bring to market groundbreaking treatments for individuals suffering from rare neurological disorders that currently lack effective medical solutions.
Harmony Biosciences has raised $485M across 2 funding rounds on record, the most recent an undisclosed round of $185M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Harmony Biosciences Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Harmony Biosciences Funding Rounds
Harmony Biosciences raised $300M in a Post-IPO Debt announced in Aug 2021.
1.9 years later, an undisclosed round of $185M was announced in Jul 2023.
Harmony Biosciences Founders and Leadership Team
Contact details for the Harmony Biosciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Harmony Biosciences Funding Compared to Other Biotechnology Startups
Harmony Biosciences' latest round of $185M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Harmony Biosciences in Biotechnology and Plymouth Meeting
Companies Similar to Harmony Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Harmony Biosciences Funding FAQs
What does Harmony Biosciences do?
Harmony Biosciences, located in Plymouth Meeting, PA, is a pharmaceutical company that was founded in October 2017. Their goal is to create and bring to market groundbreaking treatments for individuals suffering from rare neurological disorders that currently lack effective medical solutions.
How much funding has Harmony Biosciences raised?
Harmony Biosciences has raised $485M across 2 rounds on record. The most recent is an undisclosed round of $185M announced in Jul 2023.
When did Harmony Biosciences last raise funding?
Harmony Biosciences' most recent funding round on record is an undisclosed round of $185M, announced in Jul 2023.
Who founded Harmony Biosciences?
FundedIQ lists David Massie (Founder) at Harmony Biosciences.
Who is the CEO of Harmony Biosciences?
John Jacobs is listed as CEO at Harmony Biosciences.
Where is Harmony Biosciences headquartered?
Harmony Biosciences is based in Plymouth Meeting, Pennsylvania, United States.
How many employees does Harmony Biosciences have?
Harmony Biosciences is in the 251-500 employee band.
How does Harmony Biosciences' funding compare to other Biotechnology startups?
Harmony Biosciences' latest round of $185M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Harmony Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Harmony Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.